investor.amerisourcebergen.comCencora, Inc. - Investor Relations

Overview Financials Quarterly Results Annual Reports Proxy Materials SEC Filings Credit Ratings News PresentationsEvents Stock Info Stock Quote Stock Chart Historical Stock Quote Investment Calculator Dividend History Analyst Coverage ESG Governance Corporate Officers Board of Directors Committees Policies Proxy Materials ESG Resources Email Alerts Information Request Form Investor FAQs StockholderIR Contacts Investor Relations A legacy of execution excellence, strategic corporate stewardship, and shareholder value creation Overview Financials Quarterly Results Annual Reports Proxy Materials SEC Filings Credit Ratings News PresentationsEvents Stock Info Stock Quote Stock Chart Historical Stock Quote Investment Calculator Dividend History Analyst Coverage ESG Governance Corporate Officers Board of Directors Committees Policies Proxy Materials ESG Resources Email Alerts Information Request Form Investor FAQs StockholderIR Contacts Overview Financials Quarterly Results Annual Reports Proxy Materials SEC Filings Credit Ratings News PresentationsEvents Stock Info Stock Quote Stock Chart Historical Stock Quote Investment Calculator Dividend History Analyst Coverage ESG Governance Corporate Officers Board of Directors Committees Policies Proxy Materials ESG Resources Email Alerts Information Request Form Investor FAQs StockholderIR Contacts Corporate overview Cencora, formerly AmerisourceBergen, is a global healthcare solutions leader driving innovative partnerships with global manufacturers, providers, and pharmacies to improve product access and efficiency throughout the healthcare supply chain. Cencora is a global healthcare solutions leader driving innovative partnerships with global manufacturers, providers and pharmacies to improve product access and efficiency throughout the healthcare supply chainIn 2023, we intend to evolve our global brand and corporate identity to become Cencora. To learn more about our new corporate identity click hereLatest quarterly results See all quarters Financial highlights FY23 Revenue Pharmaceutical Distribution: $198,153M 1U.S. Healthcare Solutions: $202,462M 1U.S. Healthcare Solutions: $234,759M Alliance Healthcare, Global Commercialization Services, & Animal Health: $15,975M 2International Healthcare Solutions: $11,530M 2International Healthcare Solutions: $27,419M 1. Includes $139M of intersegment eliminations and primarily represents the elimination of certain Pharmaceutical Distribution Services reportable segment sales to MWI.2. Reported as Other.1. Includes $4.5M of intersegment eliminations. 2. International Healthcare Solutions includes a four-month contribution from Alliance Healthcare due to the June 2021 close of the acquisition of the business.FY23 Adjusted operating income Pharmaceutical Distribution: $2,041M Alliance Healthcare, Global Commercialization Services, & Animal Health: $615MU.S. Healthcare Solutions: $2,258MU.S. Healthcare Solutions: $2,597M International Healthcare Solutions: $390M 2International Healthcare Solutions: $693M 3. Note: FY21 GAAP Operating income of $2,354M. For more information and a reconciliation of non-GAAP financial measures, refer to the Company's Current Report on Form 8-K furnished under item 2.02 on November 4, 2021.2. Note: FY23 GAAP Operating Income of $2,341M. For more information and a reconciliation of non-GAAP financial measures, refer to the Company’s Current Report on Form 8-K furnished under item 2.02 on November 2, 2023. Cencora: By the numbers $ 250 B+ Annual revenues 46,000 Team Members 150 + Global offices Summary Annual Report Recent news See all news Events and presentations Events and presentations See all events Investor alerts To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your request, you will receive an activation email to the requested email address. You must click the activation link in order to complete your subscription. You can sign up for additional alert options at any time. At Cencora, we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance. By providing your email address below, you are providing consent to Cencora to send you the requested investor email alerts updates. Email Address * *Email Investor alert options * Press Releases Events SEC Filings Annual Reports EOD Stock Quote Presentations Unsubscribe Email Alert Sign Up Confirmation LinkedIn X Facebook Instagram Privacy Terms and Conditions Data Subject Request Cookies Policy UK Modern Slavery Act DisclosureAccesibility Policy Careers Contact Us 610.727.7000 800.640.5221 Cencora Inc. Corporate Headquarters 1 West First Avenue Conshohocken, PA 19428 Copyright © Cencora Corporation. All rights reserved. Powered By Q4 Inc. 5.122.0.3 (opens in new...